Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/bcr-2020-239762 http://scihub22266oqcxt.onion/10.1136/bcr-2020-239762 33509890!10577747!33509890     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMJ+Case+Rep 2021 ; 14 (1): ä Nephropedia Template TP {{tp|p=33509890|t=2021. Convalescent plasma for COVID-19 complicated by ARDS due to TRALI |pdf=|usr=}}{{33509890}} gab.com Text Convalescent plasma for COVID-19 complicated by ARDS due to TRALI JO: BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=33509890 #FOAvip Convalescent plasma, which contains antibodies from recovered individuals, has been used as an effective treatment for infectious diseases in the past and is currently being used as a potential treatment option for COVID-19. Multiple studies have reported this treatment to be safe. We report a case of a patient who developed acute respiratory distress syndrome (ARDS) with features suggestive of transfusion-related acute lung injury after being treated with convalescent plasma for COVID-19. We emphasise the need to be aware of the potential risk of transfusion reactions and disease worsening with convalescent plasma administration and to weigh the risk and benefits of this therapy before administration to patients and propose that further study be done regarding the potential risks of convalescent plasma. Twit Text FOAVip Convalescent plasma for COVID-19 complicated by ARDS due to TRALI ????BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=33509890 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33509890 #FOAvip English Wikipedia <ref>{{Cite pmid|33509890}}</ref> Convalescent plasma for COVID-19 complicated by ARDS due to TRALI #MMPMID33509890 Wang KY; Shah P; Pierce M BMJ Case Rep 2021[Jan]; 14 (1): ä PMID33509890show ga Convalescent plasma, which contains antibodies from recovered individuals, has been used as an effective treatment for infectious diseases in the past and is currently being used as a potential treatment option for COVID-19. Multiple studies have reported this treatment to be safe. We report a case of a patient who developed acute respiratory distress syndrome (ARDS) with features suggestive of transfusion-related acute lung injury after being treated with convalescent plasma for COVID-19. We emphasise the need to be aware of the potential risk of transfusion reactions and disease worsening with convalescent plasma administration and to weigh the risk and benefits of this therapy before administration to patients and propose that further study be done regarding the potential risks of convalescent plasma. |Adult[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/*complications/*therapy[MESH] |Diagnosis, Differential[MESH] |Female[MESH] |Humans[MESH] |Immunization, Passive/methods[MESH] |Pregnancy[MESH] |Respiratory Distress Syndrome/*complications[MESH] |SARS-CoV-2[MESH] |Transfusion-Related Acute Lung Injury/*complications[MESH]Convalescent plasma for COVID-19 complicated by ARDS due to TRALI (epmc).pdf DeepDyve Pubget Overpricing